WA
RIGL icon

WealthTrust-Arizona’s Rigel Pharmaceuticals RIGL Stock Holding History

WealthTrust-Arizona’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2K Hold
87
– – ﹤0.01% 573
2018
Q3 		$3K Hold
87
– – ﹤0.01% 559
2018
Q2 		$2K Buy
87
+6
+7% +$214 ﹤0.01% 594
2018
Q1 		$3K Sell
81
-40
-33% -$1.6K ﹤0.01% 546
2017
Q4 		$5K Sell
121
-100
-45% -$3.81K ﹤0.01% 503
2017
Q3 		$6K Hold
221
– – ﹤0.01% 479
2017
Q2 		$6K Buy
221
+20
+10% +$547 ﹤0.01% 466
2017
Q1 		$7K Buy
201
+200
+20,000% +$5.1K ﹤0.01% 442
2016
Q4 		$0 Hold
1
– – ﹤0.01% 638
2016
Q3 		$0 Sell
1
-149
-99% -$4.27K ﹤0.01% 632
2016
Q2 		$3K Hold
150
– – ﹤0.01% 520
2016
Q1 		$3K Buy
150
+40
+36% +$987 ﹤0.01% 516
2015
Q4 		$3K Hold
110
– – ﹤0.01% 539
2015
Q3 		$3K Hold
110
– – ﹤0.01% 526
2015
Q2 		$4K Buy
110
+100
+1,000% +$3.82K ﹤0.01% 524
2015
Q1 		$0 Buy
+10
New +$274 ﹤0.01% 672

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WealthTrust-Arizona's RIGL Position: Q4 2018 in Review

WealthTrust-Arizona held its Rigel Pharmaceuticals (RIGL) position steady in Q4 2018 at 87 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #573.

WealthTrust-Arizona first reported a position in RIGL in Q1 2015 and has held it in 16 quarters since. The position peaked at $7K in Q1 2017. 133 funds tracked by Wall St. Rank hold RIGL as of Q4 2018.

  • WealthTrust-Arizona held 87 shares of Rigel Pharmaceuticals worth $2K as of Q4 2018.
  • WealthTrust-Arizona left its Rigel Pharmaceuticals share count unchanged in Q4 2018.
  • Rigel Pharmaceuticals made up ﹤0.01% of WealthTrust-Arizona's portfolio in Q4 2018, its #573 holding.
  • WealthTrust-Arizona first reported a position in Rigel Pharmaceuticals in Q1 2015 and has held it in 16 quarters since.
  • WealthTrust-Arizona's Rigel Pharmaceuticals position peaked at $7K in Q1 2017.
  • 133 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2018.

Based on WealthTrust-Arizona's 13F filing for Q4 2018, filed 7 Feb 2019.